The role of NK cells in human M. Tuberculosis infection
The role of NK cells in human M. Tuberculosis infection
批准号:
7538343
负责人:
Ramakrishna Vankayalapati
金额:
$25.58万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2010-12-31
关键词:
1-Phosphatidylinositol 4-KinaseAbbreviationsActivities of Daily LivingAntibodiesAntigensAutologousBacteriaBindingBinding ProteinsBlocking AntibodiesCREB1 geneCause of DeathCell SeparationCell surfaceCellsChemicalsCommunicable DiseasesCyclic AMP-Responsive DNA-Binding ProteinCytolysisDelayed HypersensitivityDevelopmentDominant-Negative MutationEnzymesEvaluationFluoresceinFluorescein-5-isothiocyanateFluoresceinsGranzymeHLA AntigensHumanImmune responseImmune systemImmunityImmunoprecipitationIndividualInfection ControlInterferonsInterleukinsIsothiocyanatesKnowledgeLigandsLinkLyticMEKsMass Spectrum AnalysisMeasurementMeasuresMediatingMitogensMononuclearMulti-Drug ResistanceMultidrug-Resistant TuberculosisMycobacterium tuberculosisNatural ImmunityNatural Killer CellsParasitesPathway interactionsPatientsPatternPeripheral Blood Mononuclear CellPersonsPhagocytesPharmaceutical PreparationsPhosphatidylinositolsPhosphorylationPhosphotransferasesPhycoerythrinPlayProductionProteinsRecombinant ProteinsRecombinantsResearchResearch PersonnelRoleSignal PathwaySignal TransductionSignaling MoleculeSmall Interfering RNASystemT-LymphocyteTuberculin TestTuberculosisVaccinesViralVirus DiseasesWestern Blottingcrosslinkcytokinecytotoxicityexpression vectorextracellularfungusimprovedin vivoinhibitor/antagonistmethod developmentmonocytemycobacterialnovelp21-activated kinase 1pathogenperforinprogramsreceptortoolvaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): NK cells contribute to immunity against viral infection, but information on their role in defense against intracellular bacteria is limited. Innate defenses are important in the immune response to Mycobacterium tuberculosis because two-thirds of close contacts of tuberculosis patients remain healthy and have negative tuberculin skin tests. This suggests that innate immunity controls the infection before T cells recognize mycobacterial antigens and mount a delayed type hypersensitivity response. Understanding innate immunity to M. tuberculosis will enhance our capacity to develop vaccines that protect against tuberculosis, including the bioterrorist threat of multidrug-resistant tuberculosis. Recently, we found that NK cells use the NKp46 receptor to lyse M. tuberculosis infected monocytes. This proposal will characterize the mechanisms by which NK cells contribute to innate immunity against M. tuberculosis, through the following aims. 1) Identify novel ligands for NKp46 on M. tuberculosis-infected mononuclear phagocytes. NKp46 ligand(s) will be identified by immunoprecipitation, followed by mass spectrometry. The ligand will be cloned and expressed, allowing production of recombinant protein and antibodies. These tools will be used to confirm the interactions between NKp46 and its ligand(s) in vivo; 2) characterize the mechanisms by which NK cells lyse infected mononuclear phagocytes. We will evaluate the mycobacterial factors and effector mechanisms that mediate lysis of infected cells such as Fas, perforin/granzyme and ATP-mediated lysis; 3) Delineate the signaling pathways by which NKp46 mediates lysis of M. tuberculosis-Infected mononuclear phagocytes. We will use specific pathway inhibitors, measure enzyme phosphorylation and kinase activity, perform immunoprecipitation and Western blotting, and alter levels of individual signaling molecules through use of viral expression vectors expressing positive or dominant negative constructs; 4) Characterize the NK cell subpopulations that mediate lysis of M. tuberculosis-infected mononuclear phagocytes. We will study NK cell subpopulations expressing specific patterns of cell surface markers and cytokines, using multiparameter cell sorting. These studies will provide fundamental information on the innate immune responses and lay the groundwork for development of vaccines that take advantage of the functional capacity of NK cells. These findings will facilitate development of immunomodulatory strategies to boost the immune response to M. tuberculosis, including multidrug-resistant tuberculosis.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/eji.201545817
发表时间:
2016-02
期刊:
European journal of immunology
影响因子:
5.4
作者:
[Venkatasubramanian S, Tripathi D, Tucker T, Paidipally P, Cheekatla S, Welch E, Raghunath A, Jeffers A, Tvinnereim AR, Schechter ME, Andrade BB, Mackman N, Idell S, Vankayalapati R]
通讯作者:
Vankayalapati R
DOI:
10.1038/mi.2016.105
发表时间:
2017-07
期刊:
Mucosal immunology
影响因子:
8
作者:
[Venkatasubramanian S, Cheekatla S, Paidipally P, Tripathi D, Welch E, Tvinnereim AR, Nurieva R, Vankayalapati R]
通讯作者:
Vankayalapati R
A rho GDP dissociation inhibitor produced by apoptotic T-cells inhibits growth of Mycobacterium tuberculosis.
由凋亡 T 细胞产生的 rho GDP 解离抑制剂可抑制结核分枝杆菌的生长。
DOI:
10.1371/journal.ppat.1004617
发表时间:
2015
期刊:
PLoS pathogens
影响因子:
6.7
作者:
[Venkatasubramanian,Sambasivan, Dhiman,Rohan, Paidipally,Padmaja, Cheekatla,SatyanarayanaS, Tripathi,Deepak, Welch,Elwyn, Tvinnereim,AmyR, Jones,Brenda, Theodorescu,Dan, Barnes,PeterF, Vankayalapati,Ramakrishna]
通讯作者:
Vankayalapati,Ramakrishna
DOI:
10.4049/jimmunol.1102833
发表时间:
2012-07-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Dhiman R, Periasamy S, Barnes PF, Jaiswal AG, Paidipally P, Barnes AB, Tvinnereim A, Vankayalapati R]
通讯作者:
Vankayalapati R
Progress in understanding the human immune responses to Mycobacterium tuberculosis.
了解人类对结核分枝杆菌的免疫反应的进展。
DOI:
10.1016/s1472-9792(09)70004-6
发表时间:
2009
期刊:
Tuberculosis (Edinburgh, Scotland)
影响因子:
--
作者:
[Barnes,PeterF, Samten,Buka, Shams,Homayoun, Vankayalapatib,Ramakrishna]
通讯作者:
Vankayalapatib,Ramakrishna
共 6 条
Innate immune response of LTBI+HIV+ children
-
批准号:10470320
-
项目类别:
-
资助金额:$69.51万
-
财政年份:2020
-
负责人:Ramakrishna Vankayalapati
-
依托单位:
Innate immune response of LTBI+HIV+ children
-
批准号:10263218
-
项目类别:
-
资助金额:$69.51万
-
财政年份:2020
-
负责人:Ramakrishna Vankayalapati
-
依托单位:
IFN-γ independent inhibition of MTB growth in human macrophages
-
批准号:9238190
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2017
-
负责人:Ramakrishna Vankayalapati
-
依托单位:
IFN-γ independent inhibition of MTB growth in human macrophages
-
批准号:9913448
-
项目类别:
-
资助金额:$49.52万
-
财政年份:2017
-
负责人:Ramakrishna Vankayalapati
-
依托单位:
Monocyte subpopulation in HIV+LTB+ individuals and development of active TB
-
批准号:9333189
-
项目类别:
-
资助金额:$17.25万
-
财政年份:2016
-
负责人:Ramakrishna Vankayalapati
-
依托单位:
The role of NK cells in HIV and tuberculosis co-infection
-
批准号:8121984
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2011
-
负责人:Ramakrishna Vankayalapati
-
依托单位:
The role of NK cells in HIV and tuberculosis co-infection
-
批准号:8337399
-
项目类别:
-
资助金额:$18.87万
-
财政年份:2011
-
负责人:Ramakrishna Vankayalapati
-
依托单位:
Treg suppression of islet allograft rejection
-
批准号:8277367
-
项目类别:
-
资助金额:$27.92万
-
财政年份:2010
-
负责人:Ramakrishna Vankayalapati
-
依托单位:
Treg suppression of islet allograft rejection
-
批准号:8477114
-
项目类别:
-
资助金额:$26.24万
-
财政年份:2010
-
负责人:Ramakrishna Vankayalapati
-
依托单位:
The mechanisms of regulatory T-cell expansion in human Mycobacterium tuberculosis
-
批准号:8145096
-
项目类别:
-
资助金额:$35.25万
-
财政年份:2010
-
负责人:Ramakrishna Vankayalapati
-
依托单位:
Treg suppression of islet allograft rejection
-
批准号:8664335
-
项目类别:
-
资助金额:$27.92万
-
财政年份:2010
-
负责人:Ramakrishna Vankayalapati
-
依托单位:
The role of regulatory T cells in M. tuberculosis infection
-
批准号:7534987
-
项目类别:
-
资助金额:$17.19万
-
财政年份:2007
-
负责人:Ramakrishna Vankayalapati
-
依托单位:
The role of regulatory T cells in M. tuberculosis infection
-
批准号:7388348
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2007
-
负责人:Ramakrishna Vankayalapati
-
依托单位:
The role of NK cells in human M. Tuberculosis infection
-
批准号:7031660
-
项目类别:
-
资助金额:$26.85万
-
财政年份:2005
-
负责人:Ramakrishna Vankayalapati
-
依托单位:
The role of NK cells in human M. Tuberculosis infection
-
批准号:7337147
-
项目类别:
-
资助金额:$25.58万
-
财政年份:2005
-
负责人:Ramakrishna Vankayalapati
-
依托单位:
The role of NK cells in human M. Tuberculosis infection
-
批准号:6870025
-
项目类别:
-
资助金额:$25.36万
-
财政年份:2005
-
负责人:Ramakrishna Vankayalapati
-
依托单位:
The role of NK cells in human M. Tuberculosis infection
-
批准号:7152927
-
项目类别:
-
资助金额:$26.08万
-
财政年份:2005
-
负责人:Ramakrishna Vankayalapati
-
依托单位:
海外基金